TECIL Chemical & Hydro Power Ltd (TECILCHEM)

Chemicals · Chemicals · NSE · Updated 2 September 2026
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
₹9.98 ↓ 43.42% (1Y)

🎯 Key Takeaways

  • TECILCHEM is in a dormant, asset-light phase with minimal operational activity and negligible revenue, reflecting a legacy business in wind-down. The company has not generated meaningful financial performance in recent quarters, with near-zero revenue and profits, and a high P/E ratio driven by market pricing rather than fundamentals.
  • ⚠️ Persistent operational dormancy with no evidence of revenue generation or business revival.
Market Cap
₹19
P/E Ratio
499.0
P/B Ratio
-3.26
ROE
8.6%
ROCE
8.4%
Debt/Equity
0.00
Promoter
47.7%

📖 The Story

TECILCHEM is in a dormant, asset-light phase with minimal operational activity and negligible revenue, reflecting a legacy business in wind-down. The company has not generated meaningful financial performance in recent quarters, with near-zero revenue and profits, and a high P/E ratio driven by market pricing rather than fundamentals. Management appears focused on procedural compliance rather than strategic transformation, signaling limited growth ambitions.

📰 What's Happening

The most recent board meeting on August 12, 2026, approved unaudited Q1 FY26 results, which included a ₹38.90 lakh building write-off, indicating asset impairment and potential underperformance of legacy infrastructure. The reappointment of Varghese Kurian as MD-Chairman for five years underscores leadership continuity, while the scheduled AGM on September 24, 2026, with book closure from September 18–24, reflects routine governance. Earlier, on May 27, 2026, the board approved audited standalone financials for FY26 with an unmodified auditor's opinion, confirming compliance but offering no operational insights.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricMar 2009Jun 2009Sep 2009Dec 2009
Revenue0000
Operating Profit-0-0-0-0
OPM %
Net Profit-00-0-0
EPS₹0.00₹0.02₹0.00₹0.00

The company's financial trajectory remains flat and distressed, with quarterly revenue and operating metrics consistently near zero across multiple periods ending in 2009, suggesting prolonged operational stagnation. Despite the passage of time, there has been no meaningful recovery in top-line or profitability indicators, and the recent write-off of a building asset further highlights deteriorating asset quality. The absence of revenue growth or margin improvement suggests management has not yet articulated or executed a turnaround strategy.

🔮 Management Outlook & What's Next

Management has not provided forward-looking guidance or strategic commentary in the reviewed filings. The focus has been on procedural matters such as board approvals, reappointments, and regulatory compliance, including trading window closures and AGM scheduling. No commentary on future revenue drivers, margin improvement, or capital allocation strategy was disclosed in the latest board meeting or financial results announcements.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

ItemMar 2016
Equity Capital19
Reserves-25
Borrowings0
Total Liabilities9
Fixed Assets4
Investments1
Total Assets9

The balance sheet as of March 2016 shows minimal financial complexity, with total assets of ₹9 crore and no borrowings, but a negative reserve position of ₹25 crore, indicating cumulative losses eroding equity. Equity stands at ₹19 crore, suggesting a thin capital base. The absence of debt is not a sign of strength but rather reflects limited capacity to fund operations or investments. The company appears to be holding a legacy balance sheet with little reinvestment or restructuring activity.

💰 Cash Flow Statement (₹ Cr)

ItemMar 2016
Operating-0
Investing-0
Financing+1
Net Cash Flow+0

👥 Shareholding Pattern

CategoryQ2FY26Q3FY26Q4FY26Q1FY27
Promoters47.7%47.7%47.7%47.7%
FII0.0%0.0%0.0%0.0%
DII6.1%6.0%5.4%3.8%
Public41.2%41.3%41.9%43.4%
# Shareholders23,34723,40223,58023,942

Promoter holding remains stable at 47.71% over the past year, suggesting no immediate exit plans. However, Foreign Institutional Investor (FII) ownership has declined from 6.14% in Q2FY26 to 0% in Q1FY27, while Domestic Institutional Investor (DII) shareholding has also decreased from 6.14% to 3.76%. The growing number of public shareholders (23,942) may reflect retail interest but also fragmentation. The declining institutional interest raises concerns about liquidity and perceived investment quality.

⚖️ Peer Comparison — Chemicals

Company MCap (₹ Cr) P/E ROCE ROE D/E
PIDILITIND 1.67 L Cr 63.2 33.4% 24.7% 0.01
SRF 76,535 35.4 15.6% 15.4% 0.36
LINDEINDIA 54,418 99.6 17.5% 12.8% 0.00
FLUOROCHEM 52,063 85.1 9.6% 7.7% 0.34
NAVINFLUOR 44,292 56.0 22.2% 19.9% 0.31
GODREJIND 38,842 33.0 9.2% 19.8% 4.57
HSCL 34,339 42.7 20.7% 17.1% 0.16
DEEPAKNTR 24,328 31.1 15.3% 13.4% 0.26
AETHER 22,349 94.8 13.8% 10.6% 0.08
AARTIIND 19,030 35.8 9.2% 9.5% 0.68

⚠️ Risk Factors

1. Persistent operational dormancy with no evidence of revenue generation or business revival. 2. High P/E ratio (450) appears disconnected from fundamentals, implying market may be pricing in speculative recovery. 3. Negative reserves and thin equity base suggest long-term profitability challenges. 4. Declining institutional shareholding, particularly FII exit, signals lack of confidence from sophisticated investors.

🧠 Analyst's Read

TECILCHEM remains a speculative entity with no clear path to operational or financial recovery, making it a high-risk holding. Investors should monitor future disclosures for signs of strategic direction, revenue revival, or capital restructuring. Until there is tangible improvement in core business performance or management articulation of a turnaround plan, the stock is likely to remain under pressure.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-02.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TECILCHEM files new disclosures

Track TECILCHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TECILCHEM — Free

Free account · 2 AI queries/day